Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suresh Senan

Showing results (71-80 of 347) with videos related to

Pageof 35
Sort By:
Seminars in Radiation Oncology|November 24, 2004
Defining target volumes for non-small cell lung carcinomaSuresh Senan, Olivier Chapet, Frank J Lagerwaard, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 19, 2013
A brief report of 10-year trends in the use of stereotactic lung radiotherapy at a dutch academic medical centerNicolas Peguret, Max Dahele, Frank Lagerwaard, et al.
Acta Oncologica (Stockholm, Sweden)|February 23, 2016
Can the probability of radiation esophagitis be reduced without compromising lung tumor control: A radiobiological modeling studyDaan Hoffmans, Max Dahele, Suresh Senan, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 7, 2022
Beyond Checkpoint Inhibitors: Enhancing Antitumor Immune Response in Lung CancerRachel E Sanborn, Famke L Schneiders, Suresh Senan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 20, 2007
Reply: Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small cell lung cancerJan P Van Meerbeeck, Paul E Y Van Schil, Suresh Senan, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 1, 2025
Reply to: Response to Gooijer and colleagues concerning 'Metastasectomy versus stereotactic body radiotherapy for patients with oligometastastic colorectal lung metastases: a systematic review'Simone A Gooijer, Suresh Senan, Famke L Schneiders, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 7, 2013
Outcomes of stereotactic ablative radiotherapy for central lung tumours: a systematic reviewSashendra Senthi, Cornelis J A Haasbeek, Ben J Slotman, et al.
The Oncologist|June 22, 2014
Measuring the population impact of introducing stereotactic ablative radiotherapy for stage I non-small cell lung cancer in CanadaAlexander V Louie, George B Rodrigues, David A Palma, et al.
The Lancet. Oncology|February 13, 2016
Stereotactic radiotherapy or surgery for early-stage non-small-cell lung cancer - Authors' replyJoe Y Chang, Suresh Senan, Egbert F Smit, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 11, 2012
Propensity-score matched pair comparison of whole brain with simultaneous in-field boost radiotherapy and stereotactic radiosurgeryGeorge Rodrigues, Jaap Zindler, Andrew Warner, et al.
Pageof 35

Showing results (71-80 of 347) with videos related to

Sort By:
Pageof 35
Seminars in Radiation Oncology|November 24, 2004
Defining target volumes for non-small cell lung carcinomaSuresh Senan, Olivier Chapet, Frank J Lagerwaard, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 19, 2013
A brief report of 10-year trends in the use of stereotactic lung radiotherapy at a dutch academic medical centerNicolas Peguret, Max Dahele, Frank Lagerwaard, et al.
Acta Oncologica (Stockholm, Sweden)|February 23, 2016
Can the probability of radiation esophagitis be reduced without compromising lung tumor control: A radiobiological modeling studyDaan Hoffmans, Max Dahele, Suresh Senan, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 7, 2022
Beyond Checkpoint Inhibitors: Enhancing Antitumor Immune Response in Lung CancerRachel E Sanborn, Famke L Schneiders, Suresh Senan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 20, 2007
Reply: Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small cell lung cancerJan P Van Meerbeeck, Paul E Y Van Schil, Suresh Senan, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 1, 2025
Reply to: Response to Gooijer and colleagues concerning 'Metastasectomy versus stereotactic body radiotherapy for patients with oligometastastic colorectal lung metastases: a systematic review'Simone A Gooijer, Suresh Senan, Famke L Schneiders, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 7, 2013
Outcomes of stereotactic ablative radiotherapy for central lung tumours: a systematic reviewSashendra Senthi, Cornelis J A Haasbeek, Ben J Slotman, et al.
The Oncologist|June 22, 2014
Measuring the population impact of introducing stereotactic ablative radiotherapy for stage I non-small cell lung cancer in CanadaAlexander V Louie, George B Rodrigues, David A Palma, et al.
The Lancet. Oncology|February 13, 2016
Stereotactic radiotherapy or surgery for early-stage non-small-cell lung cancer - Authors' replyJoe Y Chang, Suresh Senan, Egbert F Smit, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 11, 2012
Propensity-score matched pair comparison of whole brain with simultaneous in-field boost radiotherapy and stereotactic radiosurgeryGeorge Rodrigues, Jaap Zindler, Andrew Warner, et al.
Pageof 35